Genetics - Ch. 13 Flashcards
3 main genetic mutation types that cause WBC cancer
- Pro-growth arrested differentiation (MYC, RTK)
- Txn factor increased self-renewal (MLL, PML-RARA)
- Decreased apoptosis (BCL2)
NOTCH1
T-ALL or worse prognosis of CLL
t(12;21) RUNX1-ETV6
B-ALL
TdT
Pre-B and Pre-T lymphoblasts (ALL)
CD1-8
Exception?
T cells (CD5 is some B cells)
t(9;22) BCR-ABL
B-ALL, CML
Deletions of 13q, 11q, 17p
CLL/SLL
BTK activation via kinase cascade
CLL/SLL
CD19, CD20
B cells (Pre-B, mature B- NOT plasma cells)
t(14;18) BCL2 overexpression
- Follicular lymphoma
- DLBCL (from FL)
MLL2 histone methyltransferase mutation
Follicular lymphoma
BCL6 dysregulation
Diffuse large B-cell lymphoma
KSHV/HHV-8 infection
Primary effusion lymphoma (DLBCL subtype)
Translocation w/ chromosome 8 – t(8;14) usually
Burkitt lymphoma (Chromosome 8 = MYC gene, Chromosome 14 = Ig locus)
High cyclin D1, CD19, CD20, IgM and IgD w/ light chains, CD5+, CD23-
Mantle cell lymphoma
Monoclonal IgM secretion, MYD88 mutation, CD20+
Lymphoplasmacytic lymphoma
MALT1 or BCL10 fusion genes
Extranodal marginal zone lymphoma - secondary mutations that render the disease antigen-independent
t(11;18)
Extranodal marginal zone lymphoma
BRAF activation mutations
Hairy cell leukemia
t(11;14) cyclin-D1 - IgH fusion gene
Mantle cell lymphoma
Diverse rearrangements involving IgH
Multiple myeloma
Trisomy 12q
CLL/SLL
HTLV-1
Adult T-cell leukemia/lymphoma
ALK rearrangements
Anaplastic large-cell lymphoma
STAT3 point mutations
Large granular lymphocytic leukemia
CD45
Leukocyte common antigen (all leukocytes)
CD30
Activated B cells, T cells, monocytes, RS cells
CD34
Pluripotent hematopoietic stem cells and early progenitors
CD23, CD5, CD19, CD20
CLL/SLL
IgM, CD19, CD20, CD10, BCL6
Germinal center B cell
How to tell Burkitt lymphoma from other germinal center B cell neoplasms?
Burkitt = NO BCL2 expression
CD11c, CD25, CD103, annexin A1
Hairy cell leukemia
PAX5, CD15, CD30
Nodular sclerosis HL
CD20, BCL6, multilobed nucleus like popcorn kernel
L&H RS cell variant - Lymphocyte predominance HL
JAK2 tyrosine kinase mutations
PCV, ET, or PM
CD5+, B cells
- Mantle cell lymphoma
- CLL/SLL
Hyperdiploidy, hypodiploidy
B cell neoplasms
Monosomy 5, 7
MDS, AML via MDS
Deletions 5q, 7q, 20q
MDS, AML via MDS
Trisomy 8
MDS